Cancer and the Combination Approach
Jazz Pharmaceuticals, led by Liz Henderson, focuses on innovating oncology drug manufacturing to address supply chain issues in the pharmaceutical industry. The company emphasizes the importance of reliable drug supply for effective treatments in oncology.
03/28/2024 - 10:15 AM
Oncology is a tricky sector in which to innovate, but we can start by optimizing existing combination approaches
NORTHAMPTON, MA / ACCESSWIRE / March 28, 2024 / Jazz Pharmaceuticals
By Liz Henderson
Liz Henderson, Sr. Vice President Technical Operations at Jazz Pharmaceuticals discusses pioneering innovation in oncology and the importance of the manufacturing infrastructure to help achieve drug development goals.
Originally published by the Medicine Maker
Historically, innovation in the pharmaceutical industry has centered around the discovery of active pharmaceutical ingredients. A new, potentially life-saving treatment, however, can only make a difference if physicians can access a reliable supply. Drug shortages in oncology are not new. The global COVID-19 pandemic saw an increase in critical supply chain issues in the manufacture of drugs, which even further underscored the need for continued advancements in the manufacturing of oncology medicines.
Continue reading here
Credit: Author supplied
View additional multimedia and more ESG storytelling from Jazz Pharmaceuticals on 3blmedia.com.
Contact Info: https://www.3blmedia.com/profiles/jazz-pharmaceuticals info@3blmedia.com
SOURCE: Jazz Pharmaceuticals
press release on accesswire.com
What sector does Jazz Pharmaceuticals focus on innovating in?
Jazz Pharmaceuticals focuses on innovating in the oncology sector.
Who is the Senior Vice President Technical Operations at Jazz Pharmaceuticals?
Liz Henderson is the Senior Vice President Technical Operations at Jazz Pharmaceuticals.
What is the primary focus of Jazz Pharmaceuticals in drug development?
Jazz Pharmaceuticals emphasizes the importance of manufacturing infrastructure to achieve drug development goals.
What issues in drug manufacturing did the global COVID-19 pandemic highlight?
The global COVID-19 pandemic highlighted critical supply chain issues in the manufacture of drugs, particularly in oncology.
Where can the original press release be viewed?
The original press release can be viewed on accesswire.com.
JAZZ Rankings
#2855 Ranked by Stock Gains
JAZZ Stock Data
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Tags
Health Technology, Pharmaceuticals: Other, Manufacturing, Pharmaceutical Preparation Manufacturing
Country
Ireland
City
Dublin
About JAZZ
jazz pharmaceuticals plc (nasdaq: jazz) is an international biopharmaceutical company focused on improving patients’ lives by identifying, developing and commercializing meaningful products that address unmet medical needs. we are a diverse company of over 875 employees focused on portfolio of products and/or product candidates in the areas of sleep, hematology/oncology and pain. founded in 2003 and headquartered in dublin, ireland, jazz pharmaceuticals has u.s. offices in palo alto, ca and philadelphia, pa, and has offices in various other locations in europe. the company’s maintains a highly collaborative and entrepreneurial culture where employees focus on how they accomplish success as well as what is done to accomplish results by operating in accordance with the company’s core values: integrity, collaboration, passion, innovation and the pursuit of excellence. we plan to build upon our portfolio of products through acquisition and/or in-licensing activities, and leveraging our uni
